Homology Modelling and Molecular Docking Studies of Spike Protein in SARS-CoV-2

spike protein Docking (animal) Homology Sequence homology
DOI: 10.13005/bbra/3321 Publication Date: 2024-12-31T07:11:24Z
ABSTRACT
ABSTRACT: The COVID-19 pandemic, caused by SARS-CoV-2, has posed substantial global health challenges, highlighting the urgent need for effective antiviral treatments. This study utilizes homology and molecular docking to identify potential natural compound inhibitors targeting SARS-CoV-2 spike protein. protein sequence was sourced from Swiss-Prot database modeled using MODELLER 10.3, employing templates Protein Data Bank (PDB). constructed model underwent validation via Ramachandran plot analysis MolProbity scores, confirming its reliability subsequent analyses. Virtual screening of performed AutoDock Vina. Compounds exhibiting highest binding affinities were subjected MD simulations evaluate their stability. Tetrandrine (L1) Tubocurarine (L2) emerged as top candidates, with demonstrating lowest energy best fit. ADMET properties these compounds assessed SwissADME, affirming drug-like potential. Molecular dynamics further substantiated stability Tetrandrine-spike complex, revealing significant interactions. identifies a promising inhibitor warranting exploration drug development.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (30)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....